Anticancer Research

Current Issue

January 2022 (Vol. 42 Issue 1) Table of Contents

Issue highlights

Adaptive Lumpectomy Boost Planning Can Reduce Normal Tissue Exposure in Patients Receiving Hypofractionated Whole Breast Irradiation
Survival After Minimally Invasive Surgery in Older Women With Endometrial Carcinoma
Health-related Quality of Life in Intermediate- or High-risk Patients Treated With Radical External Radiotherapy and Adjuvant Docetaxel for Localized Prostate Cancer: A Randomized, Phase III SPCG-13 Study
A Single Nucleotide Polymorphism (SNP) in the SLC22A3 Transporter Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant Followed by Melphalan Therapy
Development of an Automatic Measurement Method for CD8 and PD-1 Positive T Cells Using Image Analysis Software

Special Issue of ANTICANCER RESEARCH 2021 on NEW ANTICANCER AGENTS

Topics:

A. Experimental studies on “Νew Anticancer Agents”

1. Synthesis and evaluation in vitro and in vivo
2. Mechanism of action
3. Reversal of resistance to anticancer agents
4. Oncolytic viruses

B. Clinical studies on “New Anticancer Agents”

1. Pharmacology
2. Clinical trials
3. Combination chemotherapy
4. Immunotherapeutic agents
5. New methodologies in drug delivery
6. Vaccines

Latest Articles

You have access
Clinical Significance of Expression of Immunoadjuvant Molecules (LAG-3, TIM-3, OX-40) in Neoadjuvant Chemotherapy for Breast Cancer
YUKA ASANO, SHINICHIRO KASHIWAGI, KOJI TAKADA, SAE ISHIHARA, WATARU GOTO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research January 2022, 42 (1) 125-136; DOI: https://doi.org/10.21873/anticanres.15466
You have access
Diagnostic and Prognostic Impact of Crypt Branching in Patients With Ulcerative Colitis: A Validation Study
CORINNA LANG-SCHWARZ, CARLOS A. RUBIO and MICHAEL VIETH

Anticancer Research January 2022, 42 (1) 147-154; DOI: https://doi.org/10.21873/anticanres.15468
You have access
Mac-2 Binding Protein Glycosylation Isomer as a Prognostic Marker for Hepatocellular Carcinoma With Sustained Virological Response
NORIFUMI HARIMOTO, SHINJI ITOH, TAKAHIRO YAMANAKA, KEI HAGIWARA, NORIHIRO ISHII, MARIKO TSUKAGOSHI, AKIRA WATANABE, KENICHIRO ARAKI, TOMOHARU YOSHIZUMI and KEN SHIRABE

Anticancer Research January 2022, 42 (1) 245-251; DOI: https://doi.org/10.21873/anticanres.15479
You have access
Moderate Intensity Endurance and Resistance Exercise Attenuates Cachexia in Tumor-bearing Mice
NICOLE R. WOOD, JACOB GARRITSON, ALISSA MATHIAS, JAMES M. HAUGHIAN and REID HAYWARD

Anticancer Research January 2022, 42 (1) 397-405; DOI: https://doi.org/10.21873/anticanres.15498
You have access
Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer
JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG

Anticancer Research January 2022, 42 (1) 349-353; DOI: https://doi.org/10.21873/anticanres.15492
You have access
The Clinical Desire for Pressurized Intraperitoneal Aerosol Chemotherapy in South Korea: An Electronic Survey-based Study
EUN JI LEE, SOO JIN PARK, JEESUN LEE, JAEHEE MUN, HAERIN PAIK, AERAN SEOL, JUNHWAN KIM, GA WON YIM, SEUNG-HYUK SHIM, HEE SEUNG KIM, SUK-JOON CHANG and on behalf of the KoRIA Trial Group

Anticancer Research January 2022, 42 (1) 363-371; DOI: https://doi.org/10.21873/anticanres.15494

Visit the official website of Anticancer Research.

Main menu

User menu

Search

Current Issue

Issue highlights

Featured Articles

Latest Articles